secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELLAS Life Sciences Group, Inc. (SLS)
CIK:        0001390478
Form:       8-K
Filed at:   2026-06-02T12:30:40+00:00
Accession:  0001104659-26-069251
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SELLAS Life Sciences raised $28.7M from warrant exercises in Apr-May 2026
-------------------------------------------------------------------------

- Received approximately $28.7 million in proceeds from warrant exercises during April and May 2026.
- Cash and cash equivalents were $107.1 million as of March 31, 2026; now increased by warrant proceeds.
- Common shares outstanding as of June 2, 2026: 196,632,574.
- No other material events disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1390478/000110465926069251/0001104659-26-069251-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1390478/000110465926069251/tm2616601d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-069251

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer